Harkin, Enzi Announce FDA User Fee Committee Print
Wednesday, April 18, 2012
WASHINGTON – Senators Tom Harkin (D-IA) and Mike Enzi (R-WY), Chairman and Ranking Member of the Senate Health, Education, Labor and Pensions (HELP) Committee, today announced the release of the Food and Drug Administration Safety and Innovation Act Committee Print that will be considered at next Wednesday’s Committee markup.
“This document represents a strong, bipartisan step towards the authorization of critically important legislation to ensure that the FDA can approve drugs, medical devices, generic drugs and biosimilars. Failure to reauthorize the current user fee programs in a timely way threatens biomedical industry jobs, patient access to new therapies, and America’s global leadership in biomedical innovation.
“We are continuing to work with our colleagues on the Best Pharmaceuticals for Children Act, the Pediatric Research Equity Act, and the Pediatric Medical Device Safety and Improvement Act. These are vital pediatrics laws that have improved the safety and efficacy of drugs for millions of children and have stimulated the development of pediatric medical devices, and we are committed to their reauthorization.”
- Murray, Isakson Urge FDA to Issue Updated Guidance to Pregnant Women on Seafood Consumption [Ranking Member]
- Murray Joins Advocates to Build on Momentum for Expanding Access to Paid Sick Days [Ranking Member]
- #HFAnow: Murray Launches New Tool to Hear Stories on Paid Sick Days [Ranking Member]
- Alexander Says He Will Fight NLRB Attempt to Undermine State Right-to-Work Laws [Chairman]
- Strong Support for Bipartisan Legislative Agreement to “Fix No Child Left Behind” [Chairman]
- BIPARTISAN NCLB FIX PASSES SENATE COMMITTEE: Murray Calls for Continued Bipartisan Work to Move Bill Through Senate, Get Signed into Law [Ranking Member]